临床外科杂志 ›› 2025, Vol. 33 ›› Issue (11): 1159-1164.doi: 10.3969/j.issn.1005-6483.20241896

• 论著 • 上一篇    下一篇

非小细胞肺癌癌组织POK红系髓性致癌因子、FUNDC1、p27表达联合预测NSCLC术后5年无瘤生存的效能分析

  

  1. 810000  青海西宁,青海大学附属医院胸外科(虎建国、沙闯、白成云、李文军),康复科(严霞怡)
  • 收稿日期:2024-11-28 接受日期:2024-11-28 出版日期:2025-11-20 发布日期:2025-11-20
  • 通讯作者: 严霞怡,Email:648400173@qq.com
  • 基金资助:
    青海省医药卫生科研项目(090NKCA01250)

Analysis of the efficacy of the combined expression of Pokemon,FUNDC1,and p27 in predicting 5-year tumor-free survival after surgery for NSCLC

  1. Department of Thoracic Surgery,Affiliated Hospital of Qinghai University,Xining 810000,China
  • Received:2024-11-28 Accepted:2024-11-28 Online:2025-11-20 Published:2025-11-20

摘要: 目的  分析非小细胞肺癌癌组织POK红系髓性致癌因子(Pokemon)、线粒体自噬受体蛋白FUNDC1、p27表达联合预测非小细胞肺癌(NSCLC)术后5年无瘤生存的效能。方法 选取2018年1月~2019年9月收治的189例行手术治疗NSCLC病人进行前瞻性研究。根据术后5年是否无瘤生存分为无瘤组、非无瘤组。应用最近邻匹配法的倾向性评分匹配(PSM)来降低组间选择偏倚。比较PSM前后两组的一般资料、手术标本Pokemon、FUNDC1、p27表达,运用多因素Logistic回归分析NSCLC术后5年无瘤生存的相关影响因素,受试者工作特征(ROC)曲线分析手术标本Pokemon、FUNDC1、p27表达预测NSCLC术后5年无瘤生存的价值,Kappa值检验联合预测结果与临床实际结果的一致性。另选本院不同时期的30例病人对联合预测价值进行外部检验,运用Kappa值检验联合预测结果与临床实际结果的一致性。结果 PSM前两组临床分期、淋巴结转移、脉管癌栓比较,差异有统计学意义(P<0.05),年龄、性别、体质量指数(BMI)、家族肿瘤史、既往史、肿瘤直径、肿瘤部位、病理类型比较,差异无统计学意义(P>0.05),PSM后两组以上基线资料比较,差异均无统计学意义(P>0.05)。非无瘤组手术标本Pokemon、FUNDC1表达高于无瘤组,p27表达低于无瘤组,两组比较差异有统计学意义(P<0.001)。多因素Logistic回归分析显示,在校正了年龄、性别等临床资料后,Pokemon升高、FUNDC1升高仍是NSCLC术后5年无瘤生存的独立相关危险因素,p27升高是NSCLC术后5年无瘤生存的独立相关保护因素(P<0.05)。绘制ROC曲线显示,Pokemon、FUNDC1、p27及联合预测NSCLC术后5年无瘤生存情况的AUC分别为0.744、0.783、0.755、0.907(P<0.001),比较不同方案的AUC显示,联合的AUC高于Pokemon、FUNDC1、p27(Z=3.297、2.673、3.100,P=0.001、0.008、0.002)。外部数据集检验显示,联合预测与临床实际结果的一致性为90.00%,Kappa值为0.769(P<0.001)。结论 手术标本Pokemon、FUNDC1、p27表达与NSCLC术后5年无瘤生存有关,联合检测能提高预测价值,有助于精确评估NSCLC切除术后的预后。

关键词: POK红系髓性致癌因子, FUNDC1, p27, 联合预测, 非小细胞肺癌, 无瘤生存

Abstract: Objective  To analyze the efficacy of the expression of POK erythroid myeloid carcinogenic factor (Pokemon),mitochondrial autophagy receptor protein FUNDC1,and p27 in predicting the 5-year tumor free survival of non-small cell lung cancer (NSCLC) patients after surgery.Methods A prospective study was conducted on 189 patients with NSCLC who underwent surgical treatment in our hospital from January 2018 to September 2019.According to whether there was tumor free survival after 5 years,patients were divided into tumor-free group and non-tumor-free group.The propensity score matching (PSM) method using the nearest neighbor matching method was applied to reduce selection bias between groups.The general information,surgical specimens Pokemon,FUNDC1,and p27 expression were compared between the two groups before and after PSM.Multivariate Logistic regression analysis was used to analyze the factors associated with 5-year tumor free survival after surgery in NSCLC.The value of the receiver operating characteristic (ROC) curve analysis of the expression of Pokemon,FUNDC1,and p27 in surgical specimens for predicting 5-year tumor free survival in NSCLC patients was investigated.The Kappa value was used to test the consistency between the combined prediction results and the actual clinical results.Results There were significant differences in clinical stage,lymph node metastasis,and vascular tumor thrombus between the first two groups of PSM (P<0.05),while there were no significant differences in age,gender,BMI,family history of cancer,past medical history,tumor diameter,tumor location,and pathological type (P>0.05),there were no significant differences in baseline data between the two groups after PSM (P>0.05),making them comparable.The expression of Pokemon and FUNDC1 in non-tumor group was higher than that in tumor group,while the expression of p27 was lower than that in tumor group (P<0.001).Multivariate Logistic regression analysis showed that after correcting for clinical data such as age and gender,Pokemon and FUNDC1 were still independent risk factors for 5-year tumor free survival after NSCLC surgery,while p27 was an independent protective factor for 5-year tumor free survival after NSCLC surgery (P<0.05).The ROC curve shows that the AUC of Pokemon,FUNDC1,p27,and the combined prediction of 5-year tumor free survival after NSCLC surgery are 0.744,0.783,0.755,and 0.907,respectively (P<0.001).Comparing the AUC of different schemes,the combined AUC is higher than that of Pokemon,FUNDC1,and p27 (Z=3.297,2.673,3.100,P=0.001,0.008,0.002).The external dataset test showed that the consistency between the joint prediction and the actual clinical results was 90.00%,with a Kappa value of 0.769 (P<0.001).Conclusion The expression of Pokemon,FUNDC1,and p27 in surgical specimens is associated with 5year tumor free survival after NSCLC surgery,showing a certain predictive ability.Combined detection can further improve the prognosis after NSCLC resection.

Key words: Pokemon, FUNDC1, p27, combined predictive, non-small cell lung cancer, tumor free survival

[1] 刘雪辉 张国超 黄宇菲 谭锋维. 非小细胞肺癌围手术期免疫治疗热点问题及研究进展[J]. 临床外科杂志, 2025, 33(9): 938-942.
[2] 王浩有 王伟 刘宏旭. 非小细胞肺癌新辅助免疫治疗的机遇与挑战[J]. 临床外科杂志, 2025, 33(9): 943-947.
[3] 杜宁彬 王居正 郭玲 胡艳正. 长链非编码RNA XIST和微小RNA-186-5p在非小细胞肺癌组织中的表达及其与病理特征的相关性[J]. 临床外科杂志, 2025, 33(9): 953-957.
[4] 程辉 李樊 赵波. 非插管视频辅助胸腔镜手术在非小细胞肺癌中的应用进展[J]. 临床外科杂志, 2025, 33(9): 1003-1006.
[5] 梁志伟 辛鑫 余会敏. 长链非编码RNA GAS5和基质金属蛋白酶9在非小细胞肺癌病人血清中的表达及临床价值[J]. 临床外科杂志, 2025, 33(5): 498-502.
[6] 仇睿 刘阳 马波 吕志平 马云帆. 切除修复交叉互补族6-样表达与非小细胞肺癌临床病理特征的关系及其预后意义[J]. 临床外科杂志, 2025, 33(3): 266-270.
[7] 龚顺松 朱炎 董轼 蔡奕欣. 非小细胞肺癌中PROM2、RALY 和Rab15表达及预测发生骨转移的价值研究[J]. 临床外科杂志, 2025, 33(3): 271-274.
[8] 彭蓉蓉, 卞家蓉, 谈王蓉. 血清神经元特异性烯醇化酶、基质细胞衍生因子1和诱饵受体3联合在非小细胞肺癌病人预后评估中的临床意义[J]. 临床外科杂志, 2025, 33(1): 92-96.
[9] 赵洁 江帆 祁涛 闫丽娟 简鸽 刘梦婷. 非小细胞肺癌表皮生长因子受体靶向治疗后病人血清微小RNA-30a-5p和微小RNA-129-5p表达与疗效的关系[J]. 临床外科杂志, 2024, 32(9): 923-926.
[10] 黄如敬 鲁洪岭 吴超 杨洪娟 尹晓明 赵阳 康华薇 田菲 孙云川. 非小细胞肺癌病人血清miR-326和miR-623表达与临床病理特征及预后的关系[J]. 临床外科杂志, 2024, 32(7): 706-710.
[11] 高超 戴希勇 蒋钰辉 刘小玉 李晶 熊浩. 非小细胞肺癌病人血清中miR-455、miR-383表达水平及其临床诊断价值分析[J]. 临床外科杂志, 2024, 32(6): 607-610.
[12] 万伟 张彬 刘勇志 井淼 王晓栋. 胸腔镜下肺叶切除、解剖性肺段切除、肺楔形切除治疗非小细胞肺癌的疗效分析[J]. 临床外科杂志, 2024, 32(3): 266-270.
[13] 苏政军 黄珊珊 陈万进. 血清纤维胶凝蛋白3、胶原三股螺旋重复蛋白1对非小细胞肺癌的诊断价值及与临床病理特征的关系[J]. 临床外科杂志, 2024, 32(2): 164-167.
[14] 季凤俊 刘伟 景仕银 吴斌 杨长刚. 非小细胞肺癌病人腔镜术后心脏并发症发生的影响因素分析及预测模型构建[J]. 临床外科杂志, 2024, 32(10): 1040-1043.
[15] 闫效坤 吴庆华 陈少慕 程泽文. 术后引流量及肺功能预测值对非小细胞肺癌病人胸腔镜肺叶切除术后肺部并发症的预测价值[J]. 临床外科杂志, 2023, 31(9): 848-851.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 宫念樵. 器官捐献供肾质量评估[J]. 临床外科杂志, 2016, 24(10): 729 .
[2] 黄洪锋. 关注公民逝世后器官捐献肾移植受体围手术期感染的预防与处理[J]. 临床外科杂志, 2016, 24(10): 732 .
[3] 邱江. 心脏死亡捐献供肾移植免疫抑制方案的选择[J]. 临床外科杂志, 2016, 24(10): 735 .
[4] 杨华;李新长;龙成美;等. 公民逝世后器官捐献供肾移植临床分析[J]. 临床外科杂志, 2016, 24(10): 747 .
[5] 陈忠;王耀东;田毅峰;等. 肝胆管结石病规范化治疗的临床分析[J]. 临床外科杂志, 2016, 24(10): 753 .
[6] 江帆;孙权;吴国俊;等. 不同引流方式对恶性梗阻性黄疸患者细胞免疫的影响[J]. 临床外科杂志, 2016, 24(10): 760 .
[7] 胡志伟;汪忠镐;张玉;等. 腹腔镜Toupet胃底折叠术治疗干燥综合征合并严重胃食管反流病两例[J]. 临床外科杂志, 2016, 24(10): 766 .
[8] 胡小平;王志维;邓宏平;等. 改良全主动脉弓置换治疗老年Stanford A型主动脉夹层[J]. 临床外科杂志, 2016, 24(10): 777 .
[9] 宋华;单若冰;张晋绥;等. 产前超声诊断对新生儿消化道梗阻性疾病手术治疗价值的观察[J]. 临床外科杂志, 2016, 24(10): 780 .
[10] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .